MEREDITH MULLINS joined the University of Arizona Cancer Center as associate director of administration.
HOWARD BAILEY was named director of the University of Wisconsin Carbone Cancer Center, effective April 1. Bailey has served as interim director since September 2013.
BEAUMONT HOSPITAL'S Cancer Institute in Royal Oak, Mich., has begun construction of a proton therapy center. This will be the first single-room proton treatment center of its kind in Michigan.
PATRICK HWU was named division head of Cancer Medicine at MD Anderson Cancer Center, effective March 4. Hwu joined MD Anderson in 2003 as the first chair of Melanoma Medical Oncology. He is also currently chair of Sarcoma Medical Oncology.
THEODORE LAWRENCE was named the director of the University of Michigan Comprehensive Cancer Center. He succeeds Max Wicha, who founded the cancer center 27 years ago. Lawrence will continue to serve as chair of radiation oncology.
VARIAN MEDICAL SYSTEMS was selected to equip and service a new national proton therapy center in Aarhus, Denmark, with the Varian ProBeam proton therapy system.
THE AMERICAN ASSOCIATION FOR CANCER RESEARCH announced 11 fellows of the AACR Academy.
JONATHAN JAROW was named acting director of the Office of Medical Policy in the FDA Center for Drug Evaluation and Research.
KAREN KNUDSEN was named interim director of the Sidney Kimmel Cancer Center and interim chair of the Department of Cancer Biology at Thomas Jefferson University.
THE MULTIPLE MYELOMA RESEARCH FOUNDATION and Inflection Biosciences announced a collaboration to test IBL-202, a dual-kinase inhibitor, in the treatment of myeloma.
